70% of cancer cases in Indonesia are only detected at a late stage.

Yet when cancer is identified early, survival chances can increase by 3–10 times, and treatment costs are significantly lower.

Now available: SPOT-MAS, a Multi Cancer Early Detection test that uses a single blood draw to detect 10 types of cancer at once.

Powered by Next Generation Sequencing technology, non-invasive, and clinically validated in Southeast Asia.

SPOT-MAS is recommended for individuals over 40 years old or those with cancer risk factors.

Don’t wait until symptoms appear to start caring.

Get early detection at your nearest PRAMITA.

One small step today can make a big difference for the future.